TNFRSF4 and ovarian cancer: However, high or positive OX-40 expression in tumor-infiltrating ICs is correlated with improved survival in cutaneous malignant melanoma, colorectal cancer, glioblastoma, non-small cell lung cancer, gastric cancer, and ovarian cancer (30–36).